The Impact of Shigellosis and Recommended Treatment in Children — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Impact of Shigellosis and Recommended Treatment in Children — Stella

Home/Diarrhea Infectious/

View on ClinicalTrials.gov

Recruiting

Back to Diarrhea Infectious trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(4 sites)

Bangladesh

icddr,b Matlab Hospital, Chāndpur

icddr,b Hospital, Dhaka

Zambia

Matero Level 1 Hospital, Lusaka

Arthur Davidson Children's Hospital, Ndola

Key details

Phase

Safety & dosing

Sponsor

Johns Hopkins Bloomberg School of Public Health

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~700 participants

Started

March 2026

Primary completion

August 2029

Age range

6 Months – 59 Months

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.